Results 111 to 120 of about 25,190 (292)

Sodium fraction excretion rate in nocturnal enuresis correlates with nocturnal polyuria and osmolality [PDF]

open access: yes, 2004
: Purpose: We verify the sodium fraction excretion rate (FE Na) and potassium fraction excretion WE K) rates in monosymptomatic nocturnal enuresis. We also correlate FE Na and FE K to urinary osmolality, nocturnal polyuria and vasopressin in the same ...
Aceto, G.   +5 more
core   +1 more source

Desmopressin treatment combined with clotting factor VIII concentrates in patients with non-severe haemophilia A: protocol for a multicentre single-armed trial, the DAVID study

open access: yesBMJ Open, 2019
Introduction Haemophilia A is an inherited bleeding disorder characterised by factor VIII (FVIII) deficiency. In patients with non-severe haemophilia A, surgery and bleeding are the main indications for treatment with FVIII concentrate.
L. Schütte   +15 more
semanticscholar   +1 more source

Targeting the vasopressin type-2 receptor for renal cell carcinoma therapy. [PDF]

open access: yes, 2020
Arginine vasopressin (AVP) and its type-2 receptor (V2R) play an essential role in the regulation of salt and water homeostasis by the kidneys. V2R activation also stimulates proliferation of renal cell carcinoma (RCC) cell lines in vitro.
Calvet, James P   +10 more
core  

Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery [PDF]

open access: yes, 1994
BACKGROUND: Patients on cardiopulmonary bypass (CPB) have an increased susceptibility to postoperative bleeding. Previous reports using desmopressin acetate (DDAVP) for the prevention of postoperative bleeding have given contradictory results, whereas ...
Arroyo, J.L. (José L.)   +5 more
core   +1 more source

Global estimation of the bleeding episodes treatable with desmopressin in von Willebrand disease and hemophilia A

open access: yesHaematologica
Desmopressin increases plasma factor VIII and von Willebrand factor in non-severe hemophilia A (Hem A) and type 1 von Willebrand disease (VWD), following intravenous infusions, subcutaneous injections or nasal spray.
Alessandro Gringeri   +4 more
doaj   +1 more source

Efficacy of intranasal desmopressin in the treatment of nocturia due to nocturnal polyuria [PDF]

open access: yes, 2005
夜間多尿に伴う夜間頻尿の患者12例(男性10例, 女性2例, 平均年齢67歳)に対して, 酢酸デスモプレシン(l0μg)鼻腔内噴霧を2週間行い, その治療効果について検討した.治療前後の排尿状況, 尿の性状, 使用状況, 合併症などを調査した結果, 平均夜間尿量は928mlから469mlに, 平均夜間尿回数は4.8回から2.8回に減少した.平均早朝尿浸透圧は420から598mOsm/kgに上昇し, 平均尿中Na濃度は100から140mEq/lに上昇した.平均血中Na濃度は141から135mEq ...
北原, 光輝   +6 more
core  

Age and urine concentration after desmopressin. [PDF]

open access: green, 1978
John P. Monson, Patricia Richards
openalex   +1 more source

The Correlation of Ultrasonographic and Pathophysiologic Measurements of Umbilical Vessels in Gestational Diabetes 1 [PDF]

open access: yes, 2017
Aim: The resistance of placental blood vessels might be increased in diabetic pregnancies. This increased resistance can affect uteroplacental blood flow and influence the oxygen and nutrient supply of the fetus and fetal growth.
Bártfai, György   +4 more
core   +2 more sources

Effects of exogenous desmopressin on a model of heat stress nephropathy in mice.

open access: yesAJP - Renal Physiology, 2017
Recurrent heat stress and dehydration have recently been shown experimentally to cause chronic kidney disease (CKD). One potential mediator may be vasopressin, acting via the type 2 vasopressin receptor (V2 receptor).
Carlos Roncal-Jimenez   +11 more
semanticscholar   +1 more source

Alarm therapy and desmopressin in the treatment of patients with nocturnal enuresis

open access: yesAfrican Journal of Paediatric Surgery, 2018
Purpose: The purpose of this study was to compare the rates of success, relapse, and compliance to treatment in patients undergoing alarm therapy or receiving desmopressin for primary monosymptomatic nocturnal enuresis (PMNE). Materials and Methods: This
Basri Cakiroglu   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy